Posted on

Breast Tissue Arrays

Need more information, quote or place an order?  Please email to: info@vitrovivo.com

 

SKU#

DESCRIPTION

CASE

CORE

Price ($)

BC08212 Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores 96 100 337.50
BR485 Breast cancer and normal tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores 48 96 517.50
BR20828 Breast cancer survey tissue array (22 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores 104 208 592.50
BR20831 Breast cancer survey tissue array (25 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores 104 208 592.50
BR20836 Breast cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 208 cases/208 cores 208 208 682.50
T089b Breast cancer tissue array (4x (2×3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T089c 6 24 60.00
BR1510 Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores 50 150 442.50
BR1202b Breast cancer tissue array (most of triple negative), including pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing BR1202a 60 120 442.50
BR1509a Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC marker (ER,PR,Her-2 and Ki-67), 50 cases/150 cores 50 150 382.50
BR1201b Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a 60 120 442.50
BR901 Breast cancer tissue array (pathology grade 1-3), including TNM and clinical stage data, 45 cases/90 cores 45 90 337.50
BR082a Breast cancer tissue array with Her-2 IHC (0-3+) control, including TNM and pathology grade, Her-2 status, 4 cases/8 cores, replaced by BR082b 4 8 97.50
BR1321 Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 120 cases/ 132 cores 120 132 592.50
BR251a Breast cancer tissue array with matched cancer adjacent breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251 6 24 60.00
BR251c Breast cancer tissue array with matched cancer adjacent breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b 6 24 60.00
BRC051 Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores 5 5 52.50
BR248a Breast cancer tissue array with normal tissue as control, including TNM and pathology grade, 24 cases/ 24 cores, replacing BR248 24 24 135.00
BR483b Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR483 48 48 277.50
BR483c Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR483b 48 48 277.50
BR2088 Breast cancer tissue array, including pathology grade, TNM and clinical stage, 104 cases/208 cores 104 208 592.50
BR727 Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores 24 72 382.50
BR728 Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BC08015 24 72 337.50
BR965 Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BRC962 48 96 315.00
BR501 Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/ 50 cores 50 50 337.50
BR1006b Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a 50 100 382.50
BR1081 Breast cancer tissue array, including pathology grade, TNM and clinical stage, 54 cases/108 cores 54 108 382.50
BR641 Breast cancer tissue array, including pathology grade, TNM and clinical stage, 64 cases/ 64 cores 64 64 337.50
BR1505f Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505e 75 150 382.50
BR803b Breast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replaced by BR803c 80 80 322.50
FISH Breast cancer tissue array, including pathology grade, TNM, clinical stage and Her-2 marker, 5 cases/5 cores 5 5 67.50
BR2089 Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 104 cases/208 cores 104 208 592.50
BR805 Breast cancer tissue array, including TNM and clinical stage, 80 cases/80 cores 80 80 382.50
BR807 Breast cancer tissue array, including TNM and clinical stage, 80 cases/80 cores 80 80 337.50
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by BR246a 12 24 82.50
BR484b Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR484a 48 48 382.50
BR1505c Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases/150 cores, replaced BR1505b 75 150 382.50
FMG08013e Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BC08013d 72 72 382.50
FMG08013f Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e 72 72 382.50
FBR-245b Breast cancer with adjacent normal tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, replacing BR245a 12 24 82.50
BRE501 Breast cancer with breast tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores 50 50 202.50
BRE502 Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 31 cases/50 cores 50 50 202.50
BR2085c Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b 188 208 682.50
FBR-087d Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c 6 24 82.50
T088e Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T088d 6 24 82.50
BR1504c Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b 75 150 382.50
BR251d Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c 6 24 60.00
BR1008a Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 96 cases/100 cores, replacing BR1008 100 100 382.50
BR201 Breast disease spectrum tissue array, including pathology grade, TNM and clinical stage, 20 cases/20 cores 20 20 270.00
BR601a Breast fibroadenoma tissue array, 30 cases/ 60 cores, replacing BR601 30 60 337.50
BR8010 Breast fibroadenoma, breast tissue and breast cancer array, including pathology grade, TNM and clinical stage, 71 cases/80 cores 71 80 382.50
PM2b-ER Breast invasive carcinoma tissue array, including pathology grade, TNM and clinical stage, 10 cases/ 10 cores 10 10 60.00
PM2A-PR Breast invasive carcinoma tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores 10 10 97.50
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing BR808, BC08014 80 80 322.50
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47 cases/80 cores, replacing BR802 47 80 322.50
BR401 Breast mastitis tissue array, 20 cases/40 cores 20 40 277.50
BR402 Breast mastitis tissue array, 20 cases/40 cores 20 40 277.50
BRN04 Breast tissue array, 4 cases/4 cores 4 4 142.50
BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores 208 208 682.50
BR20825 Breast tumor survey tissue array (19 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 104 cases/208 cores 104 208 592.50
BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores 208 208 682.50
BR20830 Breast tumor survey tissue array (24 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores 104 208 592.50
BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores 208 208 682.50
BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores 208 208 682.50
BR20824 Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores 104 208 592.50
HER2c Her-2 IHC Bio-marker control TMA, with breast invasive ductal carcinoma, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/ 10 cores, replacing Her2b 10 10 97.50
BR8017 Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores 80 80 322.50
BR351 Poorly differentiated breast cancer tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores 35 35 82.50
BRE1201 Triple negative breast cancer and normal tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 120 cases/120 cores 120 120 742.50
BRE1121 Triple negative breast cancer with normal tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 112 cases/112 cores 112 112 697.50
BR1003b Multiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003a 47 101 382.50
BR1003c Multiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003b 47 101 382.50

TMA Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.